Medical DirectorSanofi, Zurich, SwitzerlandZurich, Zurich, Switzerland
OC 01.4 - Interim analysis of joint outcomes in adult and adolescent patients with severe hemophilia A receiving efanesoctocog alfa during the phase 3 XTEND-ed long-term extension study
Saturday, June 22, 202413:45 – 14:00 ICT
